อ้างอิง ของ ภาวะคอเลสเตอรอลสูงในเลือด

  1. 1 2 3 4 Durrington, P (August 2003). "Dyslipidaemia". Lancet. 362 (9385): 717–731. doi:10.1016/S0140-6736(03)14234-1. PMID 12957096. S2CID 208792416.
  2. ↑ Behrman, EJ; Gopalan, V (December 2005). "Cholesterol and Plants". Journal of Chemical Education. 82 (12): 1791. Bibcode:2005JChEd..82.1791B. doi:10.1021/ed082p1791. ISSN 0021-9584.
  3. ↑ Biggerstaff, KD; Wooten, JS (December 2004). "Understanding lipoproteins as transporters of cholesterol and other lipids". Advances in Physiology Education. 28 (1–4): 105–106. doi:10.1152/advan.00048.2003. PMID 15319192. S2CID 30197456.
  4. ↑ Carmena, R; Duriez, P; Fruchart, JC (June 2004). "Atherogenic lipoprotein particles in atherosclerosis". Circulation. 109 (23 Suppl 1): III2–III7. doi:10.1161/01.CIR.0000131511.50734.44. PMID 15198959.
  5. ↑ Kontush, A; Chapman, MJ (March 2006). "Antiatherogenic small, dense HDL--guardian angel of the arterial wall?". Nature Clinical Practice. Cardiovascular Medicine. 3 (3): 144–153. doi:10.1038/ncpcardio0500. PMID 16505860. S2CID 27738163.
  6. ↑ "Healthy diet - Fact sheet N°394". World Health Organization. September 2015. สืบค้นเมื่อ 2016-07-06.
  7. 1 2 3 de Souza, RJ; Mente, A; Maroleanu, A; Cozma, AI; Ha, V; Kishibe, T; และคณะ (August 2015). "Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies". BMJ. 351: h3978. doi:10.1136/bmj.h3978. PMC 4532752. PMID 26268692.
  8. 1 2 3 4 5 6 Ito, MK; McGowan, MP; Moriarty, PM (June 2011). "Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia". Journal of Clinical Lipidology. 5 (3 Suppl): S38–S45. doi:10.1016/j.jacl.2011.04.001. PMID 21600528.
  9. 1 2 Official, ThaiHealth (2017-04-04). "คนไทย 26 ล้านคนไขมันในเลือดสูง". สำนักงานกองทุนสนับสนุนการสร้างเสริมสุขภาพ (สสส.). เก็บจากแหล่งเดิมเมื่อ 2024-03-15. สืบค้นเมื่อ 2024-03-15.
  10. 1 2 3 4 5 6 7 Bhatnagar, D; Soran, H; Durrington, PN (August 2008). "Hypercholesterolaemia and its management". BMJ. 337: a993. doi:10.1136/bmj.a993. PMID 18719012. S2CID 5339837.
  11. ↑ Finn, AV; Nakano, M; Narula, J; Kolodgie, FD; Virmani, R (July 2010). "Concept of vulnerable/unstable plaque". Arteriosclerosis, Thrombosis, and Vascular Biology. 30 (7): 1282–1292. doi:10.1161/ATVBAHA.108.179739. PMID 20554950.
  12. ↑ Grundy, SM; Balady, GJ; Criqui, MH; Fletcher, G; Greenland, P; Hiratzka, LF; และคณะ (May 1998). "Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association". Circulation. 97 (18): 1876–1887. doi:10.1161/01.CIR.97.18.1876. PMID 9603549.
  13. ↑ Shields, C; Shields, J (2008). Eyelid, conjunctival, and orbital tumors: atlas and textbook. Hagerstown, Maryland: Lippincott Williams & Wilkins. ISBN 978-0-7817-7578-6.
  14. ↑ Zech, LA; Hoeg, JM (March 2008). "Correlating corneal arcus with atherosclerosis in familial hypercholesterolemia". Lipids in Health and Disease. 7 (1): 7. doi:10.1186/1476-511X-7-7. PMC 2279133. PMID 18331643.
  15. 1 2 James, WD; Berger, TG (2006). Andrews' Diseases of the Skin: Clinical Dermatology. Saunders Elsevier. pp. 530–32. ISBN 978-0-7216-2921-6.
  16. ↑ Rapini, RP; Bolognia, JL; Jorizzo, JL (2007). Dermatology: 2-Volume Set. St. Louis, Missouri: Mosby. pp. 1415–16. ISBN 978-1-4160-2999-1.
  17. ↑ Calderon, R; Schneider, RH; Alexander, CN; Myers, HF; Nidich, SI; Haney, C (1999). "Stress, stress reduction and hypercholesterolemia in African Americans: a review". Ethnicity & Disease. 9 (3): 451–62. PMID 10600068.
  18. ↑ Hawkley, LC; Cacioppo, JT (October 2010). "Loneliness matters: a theoretical and empirical review of consequences and mechanisms". Annals of Behavioral Medicine. 40 (2): 218–227. doi:10.1007/s12160-010-9210-8. PMC 3874845. PMID 20652462.
  19. 1 2 Mannu, GS; Zaman, MJ; Gupta, A; Rehman, HU; Myint, PK (February 2013). "Evidence of lifestyle modification in the management of hypercholesterolemia". Current Cardiology Reviews. 9 (1): 2–14. doi:10.2174/157340313805076313. PMC 3584303. PMID 22998604.
  20. ↑ Howell, WH; McNamara, DJ; Tosca, MA; Smith, BT; Gaines, JA (June 1997). "Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis". The American Journal of Clinical Nutrition. 65 (6): 1747–1764. doi:10.1093/ajcn/65.6.1747. PMID 9174470.
  21. ↑ DiNicolantonio, JJ; Lucan, SC; O'Keefe, JH (2016). "The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease". Progress in Cardiovascular Diseases. 58 (5): 464–472. doi:10.1016/j.pcad.2015.11.006. PMC 4856550. PMID 26586275.
  22. ↑ Ascherio, A; Willett, WC (October 1997). "Health effects of trans fatty acids". The American Journal of Clinical Nutrition. 66 (4 Suppl): 1006S–1010S. doi:10.1093/ajcn/66.4.1006S. PMID 9322581.
  23. ↑ Grundy, SM (November 2016). "Does Dietary Cholesterol Matter?". Current Atherosclerosis Reports. 18 (11): 68. doi:10.1007/s11883-016-0615-0. PMID 27739004. S2CID 30969287.
  24. ↑ Vincent, MJ; Allen, B; Palacios, OM; Haber, LT; Maki, KC (January 2019). "Meta-regression analysis of the effects of dietary cholesterol intake on LDL and HDL cholesterol". The American Journal of Clinical Nutrition. 109 (1): 7–16. doi:10.1093/ajcn/nqy273. PMID 30596814.
  25. ↑ Herink, M; Ito, MK (2000-01-01). "Medication Induced Changes in Lipid and Lipoproteins". ใน De Groot, LJ; Chrousos, G; Dungan, K; Feingold, KR; Grossman, A; Hershman, JM; Koch, C; Korbonits, M; McLachlan, R (บ.ก.). Endotext. South Dartmouth (MA): MDText.com, Inc. PMID 26561699.
  26. ↑ "Hypercholesterolemia". Genetics Home Reference. U.S. National Institutes of Health. สืบค้นเมื่อ 2013-12-05.
  27. ↑ Akioyamen, LE; Genest, J; Shan, SD; Reel, RL; Albaum, JM; Chu, A; Tu, JV (September 2017). "Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis". BMJ Open. 7 (9): e016461. doi:10.1136/bmjopen-2017-016461. PMC 5588988. PMID 28864697.
  28. ↑ Slatkin, M (August 2004). "A Population-Genetic Test of Founder Effects and Implications for Ashkenazi Jewish Diseases". Am. J. Hum. Genet. American Society of Human Genetics via PubMed. 75 (2): 282–93. doi:10.1086/423146. PMC 1216062. PMID 15208782.
  29. ↑ Durst, Ronen; Colombo, Roberto; Shpitzen, Shoshi; Avi, Liat Ben; และคณะ (2001). "Recent Origin and Spread of a Common Lithuanian Mutation, G197del LDLR, Causing Familial Hypercholesterolemia: Positive Selection Is Not Always Necessary to Account for Disease Incidence among Ashkenazi Jews". The American Journal of Human Genetics. 68 (5): 1172–1188. doi:10.1086/320123. PMC 1226098. PMID 11309683.
  30. 1 2 3 4 5 6 7 8 9 10 11 Consumer Reports; Drug Effectiveness Review Project (March 2013). "Evaluating statin drugs to treat High Cholesterol and Heart Disease: Comparing Effectiveness, Safety, and Price" (PDF). Best Buy Drugs. Consumer Reports: 9. สืบค้นเมื่อ 2013-03-27. which cites
  31. ↑ "คอเลสเตอรอลและโรคหัวใจ". Bumrungrad International Hospital. เก็บจากแหล่งเดิมเมื่อ 2023-09-30. สืบค้นเมื่อ 2024-03-16.
  32. ↑ "Diagnosis and treatment". Mayo Clinic. 2023-01-11. เก็บจากแหล่งเดิมเมื่อ 2024-03-13. สืบค้นเมื่อ 2024-03-16.
  33. ↑ ATP III Guidelines At-A-Glance Quick Desk Reference, National Cholesterol Education Program. Retrieved 2013-03-09.
  34. ↑ Davidson, Michael H.; Pradeep, Pallavi (2023-07-03). "Hormonal and Metabolic Disorders". MSD Manual Consumer Version. เก็บจากแหล่งเดิมเมื่อ 2023-11-14. สืบค้นเมื่อ 2024-03-16. Although there is no natural cutoff between normal and abnormal cholesterol levels, ...
  35. ↑ "What Your Cholesterol Levels Mean". www.heart.org. 2017-11-16. เก็บจากแหล่งเดิมเมื่อ 2024-02-26. สืบค้นเมื่อ 2024-03-16. While cholesterol levels above “normal ranges” are important in your overall cardiovascular risk, like HDL and LDL cholesterol levels, your total blood cholesterol level should be considered in context with your other known risk factors.
  36. ↑ Nantsupawat, Nopakoon; Booncharoen, Apaputch; Wisetborisut, Anawat; Jiraporncharoen, Wichuda; และคณะ (2019-01-26). "Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population". Lipids in Health and Disease. 18: 28. doi:10.1186/s12944-019-0975-x. ISSN 1476-511X. PMC 6347761. PMID 30684968. The current appropriate TC cutoff to determine whether patients need further investigation and assessment is between 200 and 240 mg/dL [1, 17, 18]. However, the appropriate cut-off point for the younger population who may have low cardiovascular risk have not been examined extensively in the literature. A recent study suggests that a TC cut of point of between 200 and 240 may not be appropriate in identifying high LDL-C levels in apparently healthy people.
  37. ↑ Peters, SA; Singhateh, Y; Mackay, D; Huxley, RR; Woodward, M (May 2016). "Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: A systematic review and meta-analysis". Atherosclerosis. 248: 123–131. doi:10.1016/j.atherosclerosis.2016.03.016. PMID 27016614.
  38. 1 2 3 4 5 6 7 Reiner, Z; Catapano, AL; De Backer, G; Graham, I; Taskinen, MR; Wiklund, O; และคณะ (July 2011). "ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)". European Heart Journal. 32 (14): 1769–1818. doi:10.1093/eurheartj/ehr158. PMID 21712404.
  39. ↑ Superko, H. Robert (2009-05-05). "Advanced Lipoprotein Testing and Subfractionation Are Clinically Useful". Circulation. 119 (17): 2383–2395. doi:10.1161/CIRCULATIONAHA.108.809582. ISSN 0009-7322.
  40. ↑ "New Information on Accuracy of LDL-C Estimation". American College of Cardiology. 2020-03-20. เก็บจากแหล่งเดิมเมื่อ 2023-12-06. สืบค้นเมื่อ 2024-03-16.
  41. ↑ "Friedewald equation for calculating VLDL and LDL - All About Cardiovascular System and Disorders". Johnson's Techworld - Reliving my hobbies. 2017-11-04. เก็บจากแหล่งเดิมเมื่อ 2023-09-28. สืบค้นเมื่อ 2024-03-16.
  42. ↑ Friedewald, WT; Levy, RI; Fredrickson, DS (June 1972). "Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge". Clinical Chemistry. 18 (6): 499–502. doi:10.1093/clinchem/18.6.499. PMID 4337382.
  43. ↑ Ison, HE; Clarke, SL; Knowles, JW (1993). "Familial Hypercholesterolemia". ใน Adam, MP; Ardinger, HH; Pagon, RA; Wallace, SE (บ.ก.). GeneReviews. Seattle (WA): University of Washington, Seattle. PMID 24404629. สืบค้นเมื่อ 2021-01-04.
  44. ↑ U.S. Preventive Services Task Force. "Screening for Lipid Disorders: Recommendations and Rationale". คลังข้อมูลเก่าเก็บจากแหล่งเดิมเมื่อ 2015-02-10. สืบค้นเมื่อ 2010-11-04.
  45. ↑ Chou, R; Dana, T; Blazina, I; Daeges, M; Bougatsos, C; Jeanne, TL (October 2016). "Screening for Dyslipidemia in Younger Adults: A Systematic Review for the U.S. Preventive Services Task Force". Annals of Internal Medicine. 165 (8): 560–564. doi:10.7326/M16-0946. PMID 27538032. S2CID 20592431. {{cite journal}}: |display-authors=6 ไม่ถูกต้อง (help)
  46. ↑ Bibbins-Domingo, K; Grossman, DC; Curry, SJ; Davidson, KW; Epling, JW; García, FA; และคณะ (August 2016). "Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement". JAMA. 316 (6): 625–633. doi:10.1001/jama.2016.9852. PMID 27532917.
  47. ↑ Genest, J; Frohlich, J; Fodor, G; McPherson, R (October 2003). "Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update". CMAJ. 169 (9): 921–924. PMC 219626. PMID 14581310.
  48. ↑ "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report". Circulation. 106 (25): 3143–3421. 2002-12-17. doi:10.1161/circ.106.25.3143. ISSN 0009-7322.
  49. ↑ Spector, R; Snapinn, SM (2011). "Statins for secondary prevention of cardiovascular disease: the right dose". Pharmacology. 87 (1–2): 63–69. doi:10.1159/000322999. PMID 21228612.
  50. 1 2 3 4 Grundy, SM; Cleeman, JI; Merz, CN; Brewer, HB; Clark, LT; Hunninghake, DB; และคณะ (July 2004). "Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines". Circulation. 110 (2): 227–239. doi:10.1161/01.cir.0000133317.49796.0e. PMID 15249516.
  51. ↑ Consumer Reports; Drug Effectiveness Review Project (March 2013). "Evaluating statin drugs to treat High Cholesterol and Heart Disease: Comparing Effectiveness, Safety, and Price" (PDF). Best Buy Drugs. Consumer Reports: 9. สืบค้นเมื่อ 2013-03-27.
  52. ↑ Bhattarai, N; Prevost, AT; Wright, AJ; Charlton, J; Rudisill, C; Gulliford, MC (December 2013). "Effectiveness of interventions to promote healthy diet in primary care: systematic review and meta-analysis of randomised controlled trials". BMC Public Health. 13: 1203. doi:10.1186/1471-2458-13-1203. PMC 3890643. PMID 24355095.
  53. ↑ Hartley, L; Igbinedion, E; Holmes, J; Flowers, N; Thorogood, M; Clarke, A; และคณะ (June 2013). "Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases". The Cochrane Database of Systematic Reviews. 2013 (6): CD009874. doi:10.1002/14651858.CD009874.pub2. PMC 4176664. PMID 23736950.
  54. 1 2 Brownawell, AM; Falk, MC (June 2010). "Cholesterol: where science and public health policy intersect". Nutrition Reviews. 68 (6): 355–364. doi:10.1111/j.1753-4887.2010.00294.x. PMID 20536780.
  55. ↑ Berger, S; Raman, G; Vishwanathan, R; Jacques, PF; Johnson, EJ (August 2015). "Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis". The American Journal of Clinical Nutrition. 102 (2): 276–294. doi:10.3945/ajcn.114.100305. PMID 26109578.
  56. ↑ Keys, A; Anderson, JT; Grande, F (July 1965). "Serum cholesterol response to changes in the diet: IV. Particular saturated fatty acids in the diet". Metabolism. 14 (7): 776–787. doi:10.1016/0026-0495(65)90004-1. PMID 25286466.
  57. ↑ "Ancel Keys, PhD (1904-2004)" (PDF). National Lipid Association. สืบค้นเมื่อ 2016-08-15.
  58. ↑ Marshall, Tom (2000-01-29). "Exploring a fiscal food policy: the case of diet and ischaemic heart disease". BMJ. 320 (7230): 301–5. doi:10.1136/bmj.320.7230.301. PMC 1117490. PMID 10650031.
  59. ↑ Hegsted, DM; McGandy, RB; Myers, ML; Stare, FJ (November 1965). "Quantitative effects of dietary fat on serum cholesterol in man". The American Journal of Clinical Nutrition. 17 (5): 281–295. doi:10.1093/ajcn/17.5.281. PMID 5846902.
  60. ↑ Hegsted, D. M.; Mcgandy, R. B.; Myers, M. L.; Stare, F. J. (1965-11-01). "Quantitative Effects of Dietary Fat on Serum Cholesterol in Man". The American Journal of Clinical Nutrition (ภาษาอังกฤษ). 17 (5): 281–295. doi:10.1093/ajcn/17.5.281. ISSN 0002-9165.
  61. ↑ Grundy, Sm; Denke, Ma (1990). "Dietary influences on serum lipids and lipoproteins". Journal of Lipid Research. 31 (7): 1149–1172. doi:10.1016/S0022-2275(20)42625-2.
  62. ↑ "Scientific Report of the 2015 Dietary Guidelines Advisory Committee" (PDF). health.gov. 2015. p. 17. สืบค้นเมื่อ 2016-05-16. The 2015 DGAC will not bring forward this recommendation 644 because available evidence shows no appreciable relationship between consumption of dietary cholesterol and serum cholesterol, consistent with the conclusions of the AHA/ACC report.
  63. ↑ Hooper, L; Martin, N; Jimoh, OF; Kirk, C; Foster, E; Abdelhamid, AS (August 2020). "Reduction in saturated fat intake for cardiovascular disease". The Cochrane Database of Systematic Reviews. 2020 (8): CD011737. doi:10.1002/14651858.CD011737.pub3. PMC 8092457. PMID 32827219.
  64. ↑ Chowdhury, R; Warnakula, S; Kunutsor, S; Crowe, F; Ward, HA; Johnson, L; และคณะ (March 2014). "Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis". Annals of Internal Medicine. 160 (6): 398–406. doi:10.7326/M13-1788. PMID 24723079.
  65. ↑ Schwingshackl, L; Hoffmann, G (December 2013). "Comparison of effects of long-term low-fat vs high-fat diets on blood lipid levels in overweight or obese patients: a systematic review and meta-analysis". Journal of the Academy of Nutrition and Dietetics. 113 (12): 1640–1661. doi:10.1016/j.jand.2013.07.010. PMID 24139973. Including only hypocaloric diets, the effects of low-fat vs high-fat diets on total cholesterol and LDL cholesterol levels were abolished.
  66. ↑ Brown, L; Rosner, B; Willett, WW; Sacks, FM (January 1999). "Cholesterol-lowering effects of dietary fiber: a meta-analysis". The American Journal of Clinical Nutrition. 69 (1): 30–42. doi:10.1093/ajcn/69.1.30. PMID 9925120.
  67. ↑ Hollænder, PL; Ross, AB; Kristensen, M (September 2015). "Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies". The American Journal of Clinical Nutrition. 102 (3): 556–572. doi:10.3945/ajcn.115.109165. PMID 26269373.
  68. ↑ Schaefer, EJ; Gleason, JA; Dansinger, ML (June 2009). "Dietary fructose and glucose differentially affect lipid and glucose homeostasis". The Journal of Nutrition. 139 (6): 1257S–1262S. doi:10.3945/jn.108.098186. PMC 2682989. PMID 19403705.
  69. ↑ Grundy, SM; Stone, NJ; Bailey, AL; Beam, C; Birtcher, KK; Blumenthal, RS; และคณะ (June 2019). "2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines". Circulation. 139 (25): e1082–e1143. doi:10.1161/CIR.0000000000000625. PMC 7403606. PMID 30586774.
  70. ↑ Koskinas, KC; Siontis, GC; Piccolo, R; Mavridis, D; Räber, L; Mach, F; Windecker, S (April 2018). "Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials". European Heart Journal. 39 (14): 1172–1180. doi:10.1093/eurheartj/ehx566. PMID 29069377.
  71. ↑ Tonelli, M; Lloyd, A; Clement, F; Conly, J; Husereau, D; Hemmelgarn, B; และคณะ (November 2011). "Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis". CMAJ. 183 (16): E1189–E1202. doi:10.1503/cmaj.101280. PMC 3216447. PMID 21989464.
  72. ↑ Mills, EJ; Wu, P; Chong, G; Ghement, I; Singh, S; Akl, EA; และคณะ (February 2011). "Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials". QJM. 104 (2): 109–124. doi:10.1093/qjmed/hcq165. PMID 20934984.
  73. ↑ Mihaylova, B; Emberson, J; Blackwell, L; Keech, A; Simes, J; Barnes, EH; และคณะ (August 2012). "The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials". Lancet. 380 (9841): 581–590. doi:10.1016/S0140-6736(12)60367-5. PMC 3437972. PMID 22607822.
  74. ↑ Chou, R; Dana, T; Blazina, I; Daeges, M; Jeanne, TL (November 2016). "Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force". JAMA. 316 (19): 2008–2024. doi:10.1001/jama.2015.15629. PMID 27838722.
  75. 1 2 Taylor, F; Huffman, MD; Macedo, AF; Moore, TH; Burke, M; G, Davey Smith; และคณะ (January 2013). "Statins for the primary prevention of cardiovascular disease". The Cochrane Database of Systematic Reviews. 2013 (1): CD004816. doi:10.1002/14651858.cd004816.pub5. PMC 6481400. PMID 23440795.
  76. ↑ Pisaniello, AD; Scherer, DJ; Kataoka, Y; Nicholls, SJ (February 2015). "Ongoing challenges for pharmacotherapy for dyslipidemia". Expert Opinion on Pharmacotherapy. 16 (3): 347–356. doi:10.1517/14656566.2014.986094. PMID 25476544. S2CID 539314.
  77. ↑ Lebenthal, Y; Horvath, A; Dziechciarz, P; Szajewska, H; Shamir, R (September 2010). "Are treatment targets for hypercholesterolemia evidence based? Systematic review and meta-analysis of randomised controlled trials". Archives of Disease in Childhood. 95 (9): 673–680. doi:10.1136/adc.2008.157024. PMID 20515970. S2CID 24263653.
  78. 1 2 National Institute for Health and Clinical Excellence. Clinical guideline 67: Lipid modification. London, 2008.
  79. ↑ Navarese, EP; Kolodziejczak, M; Schulze, V; Gurbel, PA; Tantry, U; Lin, Y; และคณะ (July 2015). "Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis". Annals of Internal Medicine. 163 (1): 40–51. doi:10.7326/M14-2957. PMID 25915661. S2CID 207538324.
  80. ↑ "แนวทางเวชปฏิบัตการใช้ยารักษาภาวะไขมันผิดปกติเพื่อป้องกันโรคหัวใจและหลอดเลือด พ.ศ. ๒๕๕๙" (PDF). เก็บ (PDF)จากแหล่งเดิมเมื่อ 2023-03-03. สืบค้นเมื่อ 2024-03-18.
  81. 1 2 3 4 AMDA - The Society for Post-Acute and Long-Term Care Medicine (February 2014), "Ten Things Physicians and Patients Should Question", Choosing Wisely: an initiative of the ABIM Foundation, AMDA - The Society for Post-Acute and Long-Term Care Medicine, สืบค้นเมื่อ 2015-04-20
  82. ↑ Snow, V; Aronson, MD; Hornbake, ER; Mottur-Pilson, C; Weiss, KB (April 2004). "Lipid control in the management of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians". Annals of Internal Medicine. 140 (8): 644–649. doi:10.7326/0003-4819-140-8-200404200-00012. PMID 15096336. S2CID 6744974.
  83. ↑ Vijan, S; Hayward, RA (April 2004). "Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians". Annals of Internal Medicine. 140 (8): 650–658. doi:10.7326/0003-4819-140-8-200404200-00013. PMID 15096337. S2CID 25448635.
  84. ↑ Barnes, PM; Powell-Griner, E; McFann, K; Nahin, RL (May 2004). "Complementary and alternative medicine use among adults: United States, 2002". Advance Data. 343 (343): 1–19. PMID 15188733.
  85. ↑ Liu, ZL; Liu, JP; Zhang, AL; Wu, Q; Ruan, Y; Lewith, G; Visconte, D (July 2011). "Chinese herbal medicines for hypercholesterolemia". The Cochrane Database of Systematic Reviews (7): CD008305. doi:10.1002/14651858.CD008305.pub2. PMC 3402023. PMID 21735427.
  86. ↑ Demonty, I; Ras, RT; van der Knaap, HC; Duchateau, GS; Meijer, L; Zock, PL; และคณะ (February 2009). "Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake". The Journal of Nutrition. 139 (2): 271–284. doi:10.3945/jn.108.095125. PMID 19091798.
  87. ↑ Weingärtner, O; Böhm, M; Laufs, U (February 2009). "Controversial role of plant sterol esters in the management of hypercholesterolaemia". European Heart Journal. 30 (4): 404–409. doi:10.1093/eurheartj/ehn580. PMC 2642922. PMID 19158117.
  88. ↑ Van Craeyveld, E; Jacobs, F; Gordts, SC; De Geest, B (2011). "Gene therapy for familial hypercholesterolemia". Current Pharmaceutical Design. 17 (24): 2575–2591. doi:10.2174/138161211797247550. PMID 21774774.
  89. ↑ Al-Allaf, FA; Coutelle, C; Waddington, SN; David, AL; Harbottle, R; Themis, M (December 2010). "LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives". International Archives of Medicine. 3: 36. doi:10.1186/1755-7682-3-36. PMC 3016243. PMID 21144047.

ใกล้เคียง

ภาวะคู่หรือคี่ของ 0 ภาวะคอเลสเตอรอลสูงในเลือด ภาวะความเป็นชายเป็นพิษ ภาวะคู่หรือคี่ (คณิตศาสตร์) ภาวะคู่กันปวงกาเร ภาวะคอนเวกซ์ (เศรษฐศาสตร์) ภาวะความดันเลือดสูง ภาวะคันต่างที่ ภาวะคาร์บอนมอนอกไซด์พิษ ภาวะคิดว่าตนเขื่อง

แหล่งที่มา

WikiPedia: ภาวะคอเลสเตอรอลสูงในเลือด https://doi.org/10.1016%2FS0140-6736(03)14234-1 https://doi.org/10.1021%2Fed082p1791 https://doi.org/10.1152%2Fadvan.00048.2003 https://doi.org/10.1161%2F01.CIR.0000131511.50734.... https://doi.org/10.1038%2Fncpcardio0500 https://doi.org/10.1136%2Fbmj.h3978 https://doi.org/10.1016%2Fj.jacl.2011.04.001 https://doi.org/10.1136%2Fbmj.a993 https://doi.org/10.1161%2FATVBAHA.108.179739 https://doi.org/10.1161%2F01.CIR.97.18.1876